Literature DB >> 15767684

Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner.

Ingo H Engels1, Gudrun Totzke, Ute Fischer, Klaus Schulze-Osthoff, Reiner U Jänicke.   

Abstract

Although signaling by death receptors involves the recruitment of common components into their death-inducing signaling complexes (DISCs), apoptosis susceptibility of various tumor cells to each individual receptor differs quite dramatically. Recently it was shown that, besides caspase-8, caspase-10 is also recruited to the DISCs, but its function in death receptor signaling remains unknown. Here we show that expression of caspase-10 sensitizes MCF-7 breast carcinoma cells to TRAIL- but not tumor necrosis factor (TNF)-induced apoptosis. This sensitization is most obvious at low TRAIL concentrations or when apoptosis is assessed at early time points. Caspase-10-mediated sensitization for TRAIL-induced apoptosis appears to be dependent on caspase-3, as expression of caspase-10 in MCF-7/casp-3 cells but not in caspase-3-deficient MCF-7 cells overcomes TRAIL resistance. Interestingly, neutralization of TRAIL receptor 2 (TRAIL-R2), but not TRAIL-R1, impaired apoptosis in a caspase-10-dependent manner, indicating that caspase-10 enhances TRAIL-R2-induced cell death. Furthermore, whereas processing of caspase-10 was delayed in TNF-treated cells, TRAIL triggered a very rapid activation of caspase-10 and -3. Therefore, we propose a model in which caspase-10 is a crucial component during TRAIL-mediated apoptosis that in addition actively requires caspase-3. This might be especially important in systems where only low TRAIL concentrations are supplied that are not sufficient for the fast recruitment of caspase-8 to the DISC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767684      PMCID: PMC1061657          DOI: 10.1128/MCB.25.7.2808-2818.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

Review 1.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Signaling by the TNF receptor superfamily and T cell homeostasis.

Authors:  K F Chan; M R Siegel; J M Lenardo
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

3.  Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

Authors:  A Eggert; M A Grotzer; T J Zuzak; B R Wiewrodt; R Ho; N Ikegaki; G M Brodeur
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

4.  Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis.

Authors:  I Petak; L Douglas; D M Tillman; R Vernes; J A Houghton
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

5.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells.

Authors:  K Takeda; Y Hayakawa; M J Smyth; N Kayagaki; N Yamaguchi; S Kakuta; Y Iwakura; H Yagita; K Okumura
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

Authors:  W Roth; S Isenmann; U Naumann; S Kügler; M Bähr; J Dichgans; A Ashkenazi; M Weller
Journal:  Biochem Biophys Res Commun       Date:  1999-11-19       Impact factor: 3.575

7.  Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

Authors:  T Wieder; F Essmann; A Prokop; K Schmelz; K Schulze-Osthoff; R Beyaert; B Dörken; P T Daniel
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 8.  CD95's deadly mission in the immune system.

Authors:  P H Krammer
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

9.  Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.

Authors:  J Wang; L Zheng; A Lobito; F K Chan; J Dale; M Sneller; X Yao; J M Puck; S E Straus; M J Lenardo
Journal:  Cell       Date:  1999-07-09       Impact factor: 41.582

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  17 in total

1.  Death receptor 5 signaling promotes hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Christian D Fingas; X Wei Meng; Niklas Finnberg; Wafik S El-Deiry; Scott H Kaufmann; Gregory J Gores
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

2.  Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer.

Authors:  Xiao-Gang Shen; Cun Wang; Yuan Li; Bin Zhou; Bin Xu; Lie Yang; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2011-05-11       Impact factor: 2.571

3.  Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.

Authors:  Saman Sargazi; Armin Zahedi Abghari; Hosna Sarani; Roghayeh Sheervalilou; Shekoufeh Mirinejad; Ramin Saravani; Ebrahim Eskandari
Journal:  Appl Biochem Biotechnol       Date:  2021-08-31       Impact factor: 2.926

4.  c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.

Authors:  Travis W Day; Su Huang; Ahmad R Safa
Journal:  Biochem Pharmacol       Date:  2008-09-17       Impact factor: 5.858

5.  Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis.

Authors:  Gautam Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  Clin Immunol       Date:  2012-08-03       Impact factor: 3.969

6.  Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.

Authors:  A Mühlethaler-Mottet; M Flahaut; K Balmas Bourloud; K Nardou; A Coulon; J Liberman; M Thome; N Gross
Journal:  Cell Death Dis       Date:  2011-03-03       Impact factor: 8.469

7.  Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway.

Authors:  Yu Zhang; Elisabet Johansson; Marian L Miller; Reiner U Jänicke; Donald J Ferguson; David Plas; Jarek Meller; Marshall W Anderson
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

8.  Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.

Authors:  Mia M Gaudet; Roger L Milne; Angela Cox; Nicola J Camp; Ellen L Goode; Manjeet K Humphreys; Alison M Dunning; Jonathan Morrison; Graham G Giles; Gianluca Severi; Laura Baglietto; Dallas R English; Fergus J Couch; Janet E Olson; Xianshu Wang; Jenny Chang-Claude; Dieter Flesch-Janys; Sascha Abbas; Ramona Salazar; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Annika Lindblom; Sara Margolin; Tuomas Heikkinen; Kati Kämpjärvi; Kirsimari Aaltonen; Heli Nevanlinna; Natalia Bogdanova; Irina Coinac; Peter Schürmann; Thilo Dörk; Claus R Bartram; Rita K Schmutzler; Sandrine Tchatchou; Barbara Burwinkel; Hiltrud Brauch; Diana Torres; Ute Hamann; Christina Justenhoven; Gloria Ribas; José I Arias; Javier Benitez; Stig E Bojesen; Børge G Nordestgaard; Henrik L Flyger; Julian Peto; Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Peter A Fasching; Matthias W Beckmann; Reiner Strick; Arif B Ekici; Annegien Broeks; Marjanka K Schmidt; Flora E van Leeuwen; Laura J Van't Veer; Melissa C Southey; John L Hopper; Carmel Apicella; Christopher A Haiman; Brian E Henderson; Loic Le Marchand; Laurence N Kolonel; Vessela Kristensen; Grethe Grenaker Alnaes; David J Hunter; Peter Kraft; David G Cox; Susan E Hankinson; Caroline Seynaeve; Maaike P G Vreeswijk; Rob A E M Tollenaar; Peter Devilee; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Kamila Czene; Per Hall; Yuqing Li; Jianjun Liu; Sabapathy Balasubramanian; Saeed Rafii; Malcolm W R Reed; Karen A Pooley; Don Conroy; Caroline Baynes; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Chen-Yang Shen; Hui-Chun Wang; Jyh-Cherng Yu; Pei-Ei Wu; Hoda Anton-Culver; Argyrios Ziogoas; Kathleen Egan; Polly Newcomb; Linda Titus-Ernstoff; Amy Trentham Dietz; Alice J Sigurdson; Bruce H Alexander; Parveen Bhatti; Kristina Allen-Brady; Lisa A Cannon-Albright; Jathine Wong; Georgia Chenevix-Trench; Amanda B Spurdle; Jonathan Beesley; Paul D P Pharoah; Doug F Easton; Montserrat Garcia-Closas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

9.  Sensitizing multidrug-resistant leukemia cells to common cytostatics by an aluminium-salen complex that has high-apoptotic effects in leukemia, lymphoma and mamma carcinoma cells.

Authors:  Sina M Hopff; Liliane A Onambele; Marc Brandenburg; Albrecht Berkessel; Aram Prokop
Journal:  Biometals       Date:  2021-02-09       Impact factor: 2.949

Review 10.  Current and emerging biomarkers of cell death in human disease.

Authors:  Kongning Li; Deng Wu; Xi Chen; Ting Zhang; Lu Zhang; Ying Yi; Zhengqiang Miao; Nana Jin; Xiaoman Bi; Hongwei Wang; Jianzhen Xu; Dong Wang
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.